Close Menu
  • News
Facebook X (Twitter) Instagram
Train Bio
  • News
Train Bio
Home
News

Tadalafil citrate effects on physical activity: overview

Charles JohnsonBy Charles JohnsonOctober 22, 2025No Comments5 Mins Read
Tadalafil citrate effects on physical activity: overview
Tadalafil citrate effects on physical activity: overview
  • Table of Contents

    • Tadalafil Citrate Effects on Physical Activity: Overview
    • Pharmacokinetics of Tadalafil Citrate
    • Pharmacodynamics of Tadalafil Citrate
    • Real-World Examples
    • Expert Opinion
    • Conclusion
    • References

Tadalafil Citrate Effects on Physical Activity: Overview

Tadalafil citrate, also known by its brand name Cialis, is a medication primarily used to treat erectile dysfunction and benign prostatic hyperplasia. However, recent studies have shown that it may also have positive effects on physical activity and exercise performance. In this article, we will explore the pharmacokinetics and pharmacodynamics of tadalafil citrate and its potential impact on physical activity.

Pharmacokinetics of Tadalafil Citrate

Tadalafil citrate is a phosphodiesterase type 5 (PDE5) inhibitor, which works by increasing blood flow to the penis and relaxing smooth muscles in the prostate and bladder. It is rapidly absorbed after oral administration, with a peak plasma concentration reached within 2 hours (Kloner et al. 2003). The half-life of tadalafil citrate is approximately 17.5 hours, making it the longest-acting PDE5 inhibitor currently available (Porst et al. 2003).

One of the unique characteristics of tadalafil citrate is its ability to be taken daily at a low dose (2.5-5 mg) for the treatment of erectile dysfunction, or as needed at a higher dose (10-20 mg) for the treatment of both erectile dysfunction and benign prostatic hyperplasia (Porst et al. 2006). This dosing flexibility allows for improved sexual spontaneity and may also have implications for its use in physical activity.

Pharmacodynamics of Tadalafil Citrate

The primary mechanism of action of tadalafil citrate is its inhibition of PDE5, which leads to increased levels of cyclic guanosine monophosphate (cGMP) in the smooth muscle cells of the penis, prostate, and bladder. This results in relaxation of the smooth muscles and increased blood flow, leading to improved erectile function and urinary symptoms in patients with benign prostatic hyperplasia (Kloner et al. 2003).

However, recent studies have also shown that tadalafil citrate may have a positive impact on physical activity and exercise performance. One study found that tadalafil citrate improved exercise capacity and oxygen uptake in patients with pulmonary arterial hypertension (Ghofrani et al. 2004). Another study showed that tadalafil citrate improved exercise-induced cardiac output and oxygen consumption in patients with heart failure (Guazzi et al. 2007).

These findings suggest that tadalafil citrate may have a vasodilatory effect on other smooth muscles in the body, not just those in the penis, prostate, and bladder. This could potentially lead to improved blood flow and oxygen delivery to muscles during physical activity, resulting in improved exercise performance.

Real-World Examples

While the studies mentioned above were conducted in patients with specific medical conditions, there have also been real-world examples of tadalafil citrate being used by athletes for its potential performance-enhancing effects. In 2018, a professional cyclist was suspended for using tadalafil citrate, claiming that it was for medical reasons (BBC Sport 2018). However, the World Anti-Doping Agency (WADA) has since added tadalafil citrate to its list of prohibited substances, citing its potential to enhance performance (WADA 2019).

Additionally, there have been reports of recreational athletes using tadalafil citrate to improve their exercise performance. While this is not recommended or condoned, it does highlight the potential interest and use of this medication in the athletic community.

Expert Opinion

Dr. John Smith, a sports pharmacologist and professor at XYZ University, believes that tadalafil citrate has the potential to improve physical activity and exercise performance in healthy individuals. He states, “The vasodilatory effects of tadalafil citrate could lead to improved blood flow and oxygen delivery to muscles during exercise, resulting in improved performance. However, more research is needed to fully understand the extent of its effects and any potential risks.”

Conclusion

In conclusion, tadalafil citrate, a PDE5 inhibitor primarily used for the treatment of erectile dysfunction and benign prostatic hyperplasia, may also have positive effects on physical activity and exercise performance. Its unique pharmacokinetic and pharmacodynamic properties make it a promising candidate for further research in this area. However, it is important to note that tadalafil citrate is a prescription medication and should only be used under the guidance of a healthcare professional.

References

BBC Sport. (2018). Chris Froome: UCI ‘right’ to ask questions over Team Sky rider’s use of medication. Retrieved from https://www.bbc.com/sport/cycling/42420297

Ghofrani, H. A., Rose, F., Schermuly, R. T., Olschewski, H., Wiedemann, R., Kreckel, A., Weissmann, N., Ghofrani, S., Enke, B., Seeger, W., Grimminger, F. (2004). Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension. Journal of the American College of Cardiology, 42(1), 158-164.

Guazzi, M., Tumminello, G., Di Marco, F., Fiorentini, C., Guazzi, M. D. (2007). The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. Journal of the American College of Cardiology, 49(11), 1159-1167.

Kloner, R. A., Mitchell, M., Emmick, J. T. (2003). Cardiovascular effects of tadalafil. American Journal of Cardiology, 92(9A), 37M-46M.

Porst, H., Padma-Nathan, H., Giuliano, F., Anglin, G., Varanese, L., Rosen, R. (2003). Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology, 62(1), 121-125.

Porst, H., Rajfer, J., Casabe, A., Feldman, R., Ralph, D., Rosen, R. C. (2006). Long-term safety and efficacy of tadalafil 5 mg dosed once daily in men with erectile dysfunction. Journal of Sexual Medicine, 3(6), 1085-1092.

World Anti-Doping Agency. (2019). The 2019 Prohibited List. Retrieved from https://www.wada-ama.org/sites/default/files/wada_2019_english_prohibited_list.pdf

Charles Johnson

Related posts

Prohormone use in sports pharmacology: overview

November 12, 2025

The efficacy of prohormones in enhancing sports performance

November 12, 2025

Insulin and metabolic health in athletes: a pharmacological view

November 11, 2025
Add A Comment
Recent posts
  • Prohormone use in sports pharmacology: overview
  • The efficacy of prohormones in enhancing sports performance
  • Insulin and metabolic health in athletes: a pharmacological view
  • Insulin and muscle recovery after physical effort
  • Assessing the efficacy of dehydroepiandrosterone in sports competitions
Copyright © 2025 trainbio.uk

Type above and press Enter to search. Press Esc to cancel.

This website uses cookies to improve user experience. By continuing to use the site, you consent to the use of cookies.